Clinical Cardiology

View the latest content related to this topic

News Daily News

Risk of Another Event Remains High for Years After TIA, Minor Stroke

Researchers hope the findings will spark improvements in long-term stroke prevention for these patients.

Todd Neale

March 26, 2025

Slides

See all

Presentation ACC 2025

Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial

Presenter: Darren K. McGuire

March 29, 2025

Presentation ACC 2025

Advance-HTN: Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension

Presenter: Luke Laffin

March 29, 2025

Presentation ACC 2025

Four-Factor Prothrombin Complex Concentrate is Superior to Frozen Plasma in Bleeding Adult Cardiac Surgery Patients with Coagulopathy—Results from a Phase 3, Randomized, Active-Control Study

Presenter: Keyvan Karkouti

March 29, 2025

Presentation Controversies and Advances 2025

Management of Hyperaldosteronism: Adrenalectomy Has the Best Outcomes!

Presenter: Yufei Chen

January 30, 2025

Presentation Controversies and Advances 2025

Future Interventions for the Heart & Other Organs: “The Internet of the Human Body”

Presenter: Kalyanam Shivkumar

January 30, 2025

News

See all

News Conference News ACC 2025

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

By Michael O'Riordan

March 30, 2025

News Conference News ACC 2025

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

By Michael O'Riordan

March 29, 2025

News Daily News

Risk of Another Event Remains High for Years After TIA, Minor Stroke

By Todd Neale

March 26, 2025

News Daily News

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

By Michael O'Riordan

March 26, 2025

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

By Michael O'Riordan

March 26, 2025

AHA 2024

November 16

November 18, 2024

TCT 2024

October 27

October 30, 2024

ESC Congress 2024

August 30

September 02, 2024

Videos on This Topic

See all

Advertisement

Clinical Cardiology

Risk of Another Event Remains High for Years After TIA, Minor Stroke

Slides

Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial

Advance-HTN: Lorundrostat Efficacy and Safety in Patients with Uncontrolled Hypertension

Four-Factor Prothrombin Complex Concentrate is Superior to Frozen Plasma in Bleeding Adult Cardiac Surgery Patients with Coagulopathy—Results from a Phase 3, Randomized, Active-Control Study

Management of Hyperaldosteronism: Adrenalectomy Has the Best Outcomes!

Future Interventions for the Heart & Other Organs: “The Internet of the Human Body”

News

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

SOUL: Oral Semaglutide Bests Usual Care in High-Risk Type 2 Diabetes

Risk of Another Event Remains High for Years After TIA, Minor Stroke

ISCHEMIA: No Clinical Event Reduction With Invasive Strategy in CTO Patients

What’s Going to Be Hot at ACC 2025?

More on This Topic

Conference Coverage

AHA 2024

TCT 2024

ESC Congress 2024

Videos on This Topic

Advertisement

Clinical Cardiology

Slides

News

More on This Topic

Conference Coverage

Videos on This Topic

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content